Topical diclofenac in the treatment of actinic keratoses
- 3 January 2007
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 46 (1), 12-18
- https://doi.org/10.1111/j.1365-4632.2007.03060.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJournal of the American Academy of Dermatology, 2004
- Human Papillomaviruses in Transplant-Associated Skin CancersDermatologic Surgery, 2004
- Host cyclooxygenase-2 modulates carcinoma growthJCI Insight, 2000
- An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratosesArchives of Dermatology, 1997
- Actinic keratosesJournal of the American Academy of Dermatology, 1997
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomasArchives of Dermatology, 1995
- Angiostasis and Vascular Regression in Chronic Granulomatous Inflammation Induced by Diclofenac in Combination with Hyaluronan in MiceJournal of Pharmacy and Pharmacology, 1995
- Guidelines of care for actinic keratosesJournal of the American Academy of Dermatology, 1995
- Effect of intralesional alpha 2-interferon on actinic keratosesArchives of Dermatology, 1986